References
- World Health Organisation, Regional Office for Europe. The European Tobacco Control Report 2007. Copenhagen: World Health Organization; 2007
- Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. Jama. 2003;290:86-97
- Gratziou C. Respiratory, cardiovascular and other physiological consequences of smoking cessation. Curr Med Res Opin. 2009;25:535-545
- Kenfield SA, Stampfer MJ, Rosner BA, et al. Smoking and smoking cessation in relation to mortality in women. Jama. 2008 May 7;299:2037-2047
- West R. The clinical significance of “small” effects of smoking cessation treatments. Addiction. 2007 Apr;102:506-509
- Piasecki TM. Relapse to smoking. Clin Psychol Rev. 2006;26:196-215
- STIVORO. Actuele gegevens over roken. Available at: http://wwwstivoronl/Voor_volwassenen/Feiten___Cijfers/Actuele_gegevens_over_roken/indexaspx. Accessed December 14, 2009
- Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 2006;296:47-55
- Garrison GD, Dugan SE. Varenicline: a first-line treatment option for smoking cessation. Clin Ther 2009;31:463-491
- Wu P, Wilson K, Dimoulas P, et al. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006;6:300
- CBO KvdG. Richtlijn Behandeling van Tabaksverslaving; herziening 2009. http://www12.stivoro.nl/partnership/sup/RichtlijnTabaksverslavingActualisatie2009definitief.pdf; 2009
- Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991;86:1119-1127
- Bernaards CM, Twisk JW, Snel J, et al. Is calculating pack-years retrospectively a valid method to estimate life-time tobacco smoking? A comparison between prospectively calculated pack-years and retrospectively calculated pack-years. Addiction 2001;96:1653-1661
- STIVORO. Meetinstrumenten voor onderzoek naar roken en stoppen met roken. 2006
- West R, Hajek P, Stead L, et al. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100:299-303
- NHS. Statistics on NHS Stop Smoking Services in England, April 2008 to September 2008 (Q2 - Quarterly report). Available at: http://wwwicnhsuk/statistics-aNHnd-data-collections/health-and-lifestyles/nhs-stop-smoking-services/statistics-on-nhs-stop-smoking-services-in-england-april-2008-to-September-2008-q2–quarterly-report
- Mariano ME, Elia D, Scarascia A, et al. Smoking cessation: aspects of prevention and therapy. The activity of the Smoking Cessation Center of Parma-Italy. Acta Biomed 2009;80:42-46
- Ramon JM, Bruguera E. Real world study to evaluate the effectiveness of varenicline and cognitive-behavioural interventions for smoking cessation. Int J Environ Res Public Health 2009;6:1530-1538
- Kwaliteitsinstituut voor de Gezondheidszorg CBO. Richtlijn Behandeling van Tabaksverslaving; herziening 2009. Available at: http://www12.stivoro.nl/partnership/sup/RichtlijnTabaksverslavingActualisatie2009definitief.pdf. [Last accessed 29 March 2010]
- Tonstad S, Tonnesen P, Hajek P, et al. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA 2006;296:64-71
- Regioplan Beleidsonderzoek. Proefimplementatie ‘Stoppen met roken’ -- resultaten begeleidend onderzoek, 2009. Available at: http://www.regioplan.nl/publicaties/slug/type/rapporten/slug/proefimplementatie_stoppen_met_roken_resultaten_begeleidend_onderzoek; 2009. Accessed January 8, 2010